BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30281009)

  • 1. Impact of diabetes and metformin use on prostate cancer outcome of patients treated with radiation therapy: results from a large institutional database.
    Taussky D; Preisser F; Karakiewicz PI; Tilki D; Lambert C; Bahary JP; Delouya G; Wistaff R; Laskine M; Nguyen PV; Durand M; Saad F
    Can J Urol; 2018 Oct; 25(5):9509-9515. PubMed ID: 30281009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin Use is Associated with Improved Survival for Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy.
    Richards KA; Liou JI; Cryns VL; Downs TM; Abel EJ; Jarrard DF
    J Urol; 2018 Dec; 200(6):1256-1263. PubMed ID: 29940252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin may offer no protective effect in men undergoing external beam radiation therapy for prostate cancer.
    Ranasinghe WKB; Williams S; Ischia J; Wetherell D; Baldwin G; Shulkes A; Sengupta S; Bolton D; Patel O
    BJU Int; 2019 May; 123 Suppl 5():36-42. PubMed ID: 31012989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metformin on prostate cancer outcomes after radical prostatectomy.
    Kaushik D; Karnes RJ; Eisenberg MS; Rangel LJ; Carlson RE; Bergstralh EJ
    Urol Oncol; 2014 Jan; 32(1):43.e1-7. PubMed ID: 23810664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer.
    Rieken M; Kluth LA; Xylinas E; Fajkovic H; Becker A; Karakiewicz PI; Herman M; Lotan Y; Seitz C; Schramek P; Remzi M; Loidl W; Pummer K; Lee RK; Faison T; Scherr DS; Kautzky-Willer A; Bachmann A; Tewari A; Shariat SF
    World J Urol; 2014 Aug; 32(4):999-1005. PubMed ID: 24062093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database.
    Allott EH; Abern MR; Gerber L; Keto CJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Moorman PG; Freedland SJ
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):391-7. PubMed ID: 24100644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin effects on biochemical recurrence and metabolic signaling in the prostate.
    Winters B; Plymate S; Zeliadt SB; Holt S; Zhang X; Hu E; Lin DW; Morrissey C; Wooldridge B; Gore JL; Porter MP; Wright JL
    Prostate; 2015 Nov; 75(15):1694-703. PubMed ID: 26201966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
    Tseng CH
    Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer?
    Van De Voorde L; Janssen L; Larue R; Houben R; Buijsen J; Sosef M; Vanneste B; Schraepen MC; Berbée M; Lambin P
    Eur J Surg Oncol; 2015 Oct; 41(10):1333-9. PubMed ID: 26091848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
    Medairos RA; Clark J; Holoubek S; Kubasiak JC; Pithadia R; Hamid F; Chmielewski GW; Warren WH; Basu S; Borgia JA; Liptay MJ; Seder CW
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):55-61.e1. PubMed ID: 27157918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.
    He XX; Tu SM; Lee MH; Yeung SJ
    Ann Oncol; 2011 Dec; 22(12):2640-2645. PubMed ID: 21415239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy.
    Dong Y; Ruth KJ; Churilla TM; Viterbo R; Sobczak ML; Smaldone MC; Chen DY; Uzzo RG; Hallman MH; Horwitz EM
    Can J Urol; 2017 Feb; 24(1):8656-8662. PubMed ID: 28263132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study.
    Spratt DE; Beadle BM; Zumsteg ZS; Rivera A; Skinner HD; Osborne JR; Garden AS; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):523-531. PubMed ID: 26867881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer.
    Arrieta O; Varela-Santoyo E; Soto-Perez-de-Celis E; Sánchez-Reyes R; De la Torre-Vallejo M; Muñiz-Hernández S; Cardona AF
    BMC Cancer; 2016 Aug; 16():633. PubMed ID: 27519177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer.
    Paulus JK; Williams CD; Cossor FI; Kelley MJ; Martell RE
    Cancer Epidemiol Biomarkers Prev; 2016 Oct; 25(10):1418-1425. PubMed ID: 27496094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergism between metformin and statins in modifying the risk of biochemical recurrence following radical prostatectomy in men with diabetes.
    Danzig MR; Kotamarti S; Ghandour RA; Rothberg MB; Dubow BP; Benson MC; Badani KK; McKiernan JM
    Prostate Cancer Prostatic Dis; 2015 Mar; 18(1):63-8. PubMed ID: 25403419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality.
    Spratt DE; Zhang C; Zumsteg ZS; Pei X; Zhang Z; Zelefsky MJ
    Eur Urol; 2013 Apr; 63(4):709-16. PubMed ID: 23287698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brachytherapy Boost Utilization and Survival in Unfavorable-risk Prostate Cancer.
    Johnson SB; Lester-Coll NH; Kelly JR; Kann BH; Yu JB; Nath SK
    Eur Urol; 2017 Nov; 72(5):738-744. PubMed ID: 28688613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.
    He X; Esteva FJ; Ensor J; Hortobagyi GN; Lee MH; Yeung SC
    Ann Oncol; 2012 Jul; 23(7):1771-80. PubMed ID: 22112968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins are Associated With Increased Biochemical Recurrence After Radical Prostatectomy in Diabetic Men but no Association was Seen in Men also Taking Metformin: Results From the SEARCH Database.
    Aminsharifi A; Howard LE; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Polascik TJ; Freedland SJ
    Clin Genitourin Cancer; 2019 Feb; 17(1):e140-e149. PubMed ID: 30366879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.